Vir Biotechnology to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Vir Biotechnology will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:05 p.m. ET.

Rhea-AI Summary

Vir Biotechnology will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:05 p.m. ET. Investors can access a live webcast via the Vir website, which will be archived for 30 days. The company focuses on treating serious infectious diseases using advanced immunologic technologies, with a pipeline aimed at COVID-19, hepatitis B and D, influenza A, and HIV.

Argus Session date unavailable

-0.45% session move Open Argus

Details

News Market Reaction – VIR

The recorded move for VIR in the trading session of this news was -0.45%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the Morgan Stanley 20^th Annual Global Healthcare Conference on Tuesday, September 13, at 4:05 p.m. ET.

A live webcast of the fire side chat can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Vir Biotechnology's fireside chat at the Morgan Stanley Global Healthcare Conference?

Vir Biotechnology's fireside chat is scheduled for September 13, 2022, at 4:05 p.m. ET.

How can I access the live webcast of Vir Biotechnology's presentation?

The live webcast of Vir Biotechnology's presentation can be accessed on the company's website under Events & Presentations.

What is Vir Biotechnology focused on?

Vir Biotechnology focuses on treating and preventing serious infectious diseases through advanced immunologic technologies.

What diseases are targeted in Vir Biotechnology's development pipeline?

Vir Biotechnology's pipeline targets COVID-19, hepatitis B and D, influenza A, and HIV.

Where can I find more information about Vir Biotechnology for investors?

More information relevant to investors can be found on Vir Biotechnology's official website.